These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1411327)
1. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Lieberman JA; Alvir JM; Woerner M; Degreef G; Bilder RM; Ashtari M; Bogerts B; Mayerhoff DI; Geisler SH; Loebel A Schizophr Bull; 1992; 18(3):351-71. PubMed ID: 1411327 [TBL] [Abstract][Full Text] [Related]
2. Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates. Lieberman JA; Jody D; Alvir JM; Ashtari M; Levy DL; Bogerts B; Degreef G; Mayerhoff DI; Cooper T Arch Gen Psychiatry; 1993 May; 50(5):357-68. PubMed ID: 8489325 [TBL] [Abstract][Full Text] [Related]
3. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309 [TBL] [Abstract][Full Text] [Related]
4. Time course and biologic correlates of treatment response in first-episode schizophrenia. Lieberman J; Jody D; Geisler S; Alvir J; Loebel A; Szymanski S; Woerner M; Borenstein M Arch Gen Psychiatry; 1993 May; 50(5):369-76. PubMed ID: 8098203 [TBL] [Abstract][Full Text] [Related]
5. Symptom and demographic profiles in first-episode schizophrenia. Gelber EI; Kohler CG; Bilker WB; Gur RC; Brensinger C; Siegel SJ; Gur RE Schizophr Res; 2004 Apr; 67(2-3):185-94. PubMed ID: 14984877 [TBL] [Abstract][Full Text] [Related]
6. Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia. Lieberman JA; Alvir J; Geisler S; Ramos-Lorenzi J; Woerner M; Novacenko H; Cooper T; Kane JM Neuropsychopharmacology; 1994 Oct; 11(2):107-18. PubMed ID: 7840862 [TBL] [Abstract][Full Text] [Related]
7. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Milev P; Ho BC; Arndt S; Andreasen NC Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466 [TBL] [Abstract][Full Text] [Related]
8. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. DeLisi LE; Tew W; Xie S; Hoff AL; Sakuma M; Kushner M; Lee G; Shedlack K; Smith AM; Grimson R Biol Psychiatry; 1995 Sep; 38(6):349-60. PubMed ID: 8547454 [TBL] [Abstract][Full Text] [Related]
9. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Robinson DG; Woerner MG; Alvir JM; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Bilder R; Goldman R; Lieberman JA Am J Psychiatry; 1999 Apr; 156(4):544-9. PubMed ID: 10200732 [TBL] [Abstract][Full Text] [Related]
10. Course of treatment response in first-episode and chronic schizophrenia. Szymanski SR; Cannon TD; Gallacher F; Erwin RJ; Gur RE Am J Psychiatry; 1996 Apr; 153(4):519-25. PubMed ID: 8599400 [TBL] [Abstract][Full Text] [Related]
11. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Madsen AL; Vorstrup S; Rubin P; Larsen JK; Hemmingsen R Acta Psychiatr Scand; 1999 Aug; 100(2):119-25. PubMed ID: 10480197 [TBL] [Abstract][Full Text] [Related]
12. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Chang WC; Tang JY; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY Psychiatry Res; 2013 Oct; 209(3):353-60. PubMed ID: 23473654 [TBL] [Abstract][Full Text] [Related]
13. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856 [TBL] [Abstract][Full Text] [Related]
14. Medium-term course and outcome of schizophrenia depicted by the sixth-month subtype after an acute episode. Liu CC; Chen CH; Hwu HG; Shiu SY; Hua MS; Chen CH; Hwang TJ; Liu CM; Hsieh MH; Liu SK; Chen WJ J Formos Med Assoc; 2012 May; 111(5):265-74. PubMed ID: 22656397 [TBL] [Abstract][Full Text] [Related]
15. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. Mané A; Falcon C; Mateos JJ; Fernandez-Egea E; Horga G; Lomeña F; Bargalló N; Prats-Galino A; Bernardo M; Parellada E Schizophr Res; 2009 Oct; 114(1-3):136-43. PubMed ID: 19683418 [TBL] [Abstract][Full Text] [Related]
16. Impact of avolition and cognitive impairment on functional outcome in first-episode schizophrenia-spectrum disorder: a prospective one-year follow-up study. Chang WC; Hui CL; Chan SK; Lee EH; Chen EY Schizophr Res; 2016 Feb; 170(2-3):318-21. PubMed ID: 26778673 [TBL] [Abstract][Full Text] [Related]
17. Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments. Sato T; Bottlender R; Schröter A; Möller HJ Schizophr Res; 2004 Apr; 67(2-3):175-83. PubMed ID: 14984876 [TBL] [Abstract][Full Text] [Related]
18. A functional magnetic resonance imaging study of social cognition in schizophrenia during an acute episode and after recovery. Lee KH; Brown WH; Egleston PN; Green RD; Farrow TF; Hunter MD; Parks RW; Wilkinson ID; Spence SA; Woodruff PW Am J Psychiatry; 2006 Nov; 163(11):1926-33. PubMed ID: 17074944 [TBL] [Abstract][Full Text] [Related]
19. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Watt DC; Katz K; Shepherd M Psychol Med; 1983 Aug; 13(3):663-70. PubMed ID: 6353463 [TBL] [Abstract][Full Text] [Related]
20. Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients. Koreen AR; Lieberman J; Alvir J; Chakos M; Loebel A; Cooper T; Kane J Am J Psychiatry; 1994 Jan; 151(1):35-9. PubMed ID: 8267132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]